Marotta Asset Management Q3 2026 Portfolio Activity: Strategic Shifts in Emerging Markets and Technology
Marotta Asset Management's portfolio as of September 30, 2026, reflects significant changes, including notable purchases in emerging market exposure and adjustments within the technology sector.
As of September 30, 2026, Marotta Asset Management's portfolio totals approximately $589 million, showcasing a dynamic investment strategy focused on diversification and tactical adjustments. The firm has demonstrated a pattern of both strategic buying and selling during this quarter, with specific holdings reflecting these actions.
One of the most significant developments this quarter was the introduction of a new position in the Vanguard Emerging Markets ex-China ETF (VEXC). This ETF, which focuses on international emerging market equities outside of China, now holds a portfolio allocation of 1.3%, indicating a deliberate shift towards diversifying emerging market exposure beyond its traditional China-centric approach via the Columbia Emerging Markets Core ex-China ETF (XCEM).
Marotta also bolstered its position in the Fiduciary MSCI Consumer Staples ETF (FSTA), increasing its allocation to 2.24%. This ETF, tracking global consumer staples companies, saw a substantial rise in shares purchased, suggesting confidence in the stability and growth potential of this defensive sector. Furthermore, the firm significantly expanded its holdings in the Vanguard Information Technology ETF (VGT), adding shares to bring its allocation up to 5.66%, maintaining a strong presence in the tech space despite recent price movements.
Conversely, the firm reduced its exposure in several key areas. The Vanguard Small Cap Value ETF (VBR) allocation decreased from 5.82% to 5.51%, while the Vanguard Total International Bond ETF (BNDX) saw its allocation drop from 5.18% to 5.00% (calculated based on total value change). The firm also scaled back its position in the SPDR USA Strategic Factors ETF (QUS), reducing its allocation from 3.01% to 2.99% (calculated based on total value change), and exited the Vanguard Emerging Market Govt Bond ETF (VWOB), which previously held a 2.84% allocation.
Within the technology sector, Marotta's holdings in the SPDR S&P Biotech ETF (XBI) and the Vanguard Health Care ETF (VHT) both experienced reductions. The XBI allocation dropped from 1.55% to 1.52% (calculated based on total value change), and the VHT allocation decreased from 2.20% to 2.18% (calculated based on total value change). These adjustments, while smaller in percentage terms, still reflect a measured stance within the broader tech and healthcare themes.
Additionally, the firm made notable moves in fixed income. It sold off positions in the Schwab Short Term U.S. Treasury ETF (SCHO) and the Schwab U.S. Aggregate Bond ETF (SCHZ), reducing their allocations from 2.13% and 0.93% respectively to 2.09% and 0.90% (calculated based on total value change). This suggests a potential reallocation away from short-term Treasuries and towards other fixed income strategies or riskier assets, possibly linked to interest rate expectations or yield curve positioning.
Overall, Marotta's portfolio activity points towards a focus on emerging market diversification (particularly VEXC), strengthening its core tech and consumer staples positions, and a measured reduction in certain fixed income and healthcare holdings. For a detailed view of the current holdings, visit Marotta Asset Management. Specific stock information can be found at VOE, XCEM, and VEXC, among others.